Instil Bio, Inc.
NASDAQ:TIL
19.06 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 8.805 | 9.195 | 43.716 | 37.59 | 241.714 | 8.895 |
| Short Term Investments
| 104.51 | 141.161 | 217.204 | 416.509 | 0 | 0 |
| Cash and Short Term Investments
| 113.315 | 150.356 | 260.92 | 454.099 | 241.714 | 8.895 |
| Net Receivables
| 0 | 0 | 0 | 0 | 3.173 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 1.181 | 0 |
| Other Current Assets
| 11.155 | 10.403 | 8.458 | 19.842 | 1.251 | 0.391 |
| Total Current Assets
| 124.47 | 160.759 | 269.378 | 464.02 | 246.138 | 9.286 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 130.34 | 141.071 | 209.337 | 121.999 | 55.341 | 0.19 |
| Goodwill
| 0 | 0 | 0 | 5.722 | 5.722 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 10.104 | 10.104 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 15.826 | 15.826 | 0 |
| Long Term Investments
| 0 | 23.161 | 0 | 0.5 | 0.05 | 0 |
| Tax Assets
| 0 | 0 | 0 | -0.5 | -0.05 | 0 |
| Other Non-Current Assets
| 8.757 | 0.639 | 3.413 | 8.138 | 1.707 | 0 |
| Total Non-Current Assets
| 139.097 | 164.871 | 212.75 | 145.963 | 72.874 | 0.19 |
| Total Assets
| 263.567 | 325.63 | 482.128 | 609.983 | 319.012 | 9.476 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 0.659 | 1.212 | 2.359 | 5.568 | 3.495 | 0.979 |
| Short Term Debt
| 0 | 1.75 | 2.381 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0.524 | 0.631 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 7.237 | 7.597 | 28.048 | 35.266 | 9.155 | 0.441 |
| Total Current Liabilities
| 7.896 | 10.559 | 32.788 | 41.358 | 13.281 | 1.42 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 2.034 | 84.304 | 77.521 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 2.426 | 2.471 | 0 |
| Other Non-Current Liabilities
| 84.201 | 4.938 | 8.214 | 11 | 342.859 | 14.948 |
| Total Non-Current Liabilities
| 86.235 | 89.242 | 85.735 | 13.426 | 345.33 | 14.948 |
| Total Liabilities
| 94.131 | 99.801 | 118.523 | 54.784 | 358.611 | 16.368 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 609.983 | 331.966 | 14.948 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -655.116 | -580.981 | -424.894 | -201.717 | -44.923 | -7.185 |
| Accumulated Other Comprehensive Income/Loss
| -0.228 | -0.348 | -0.493 | -0.087 | -0.283 | 0 |
| Other Total Stockholders Equity
| 824.78 | 807.158 | 788.992 | 757.003 | -326.359 | -14.655 |
| Total Shareholders Equity
| 169.436 | 225.829 | 363.605 | 555.199 | -39.599 | -6.892 |
| Total Equity
| 169.436 | 225.829 | 363.605 | 555.199 | -39.599 | -6.892 |
| Total Liabilities & Shareholders Equity
| 263.567 | 325.63 | 482.128 | 609.983 | 319.012 | 9.476 |